APWM
AZN icon

Argonautica Private Wealth Management’s AstraZeneca AZN Stock Holding History

Argonautica Private Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,087
Closed -$806K – 184
2026
Q1 		$806K Buy
4,087
+406
+11% +$78.3K 0.24% 83
2025
Q4 		$677K Buy
3,681
+1,201
+48% +$211K 0.2% 97
2025
Q3 		$380K Buy
2,480
+205
+9% +$31K 0.11% 145
2025
Q2 		$318K Sell
2,275
-7
-0.3% -$981 0.1% 158
2025
Q1 		$335K Buy
2,282
+317
+16% +$45.9K 0.12% 152
2024
Q4 		$257K Buy
1,965
+18
+0.9% +$2.52K 0.08% 182
2024
Q3 		$303K Buy
1,947
+10
+0.5% +$1.61K 0.1% 167
2024
Q2 		$302K Buy
1,937
+74
+4% +$11.1K 0.1% 158
2024
Q1 		$252K Sell
1,863
-116
-6% -$15.4K 0.09% 179
2023
Q4 		$266K Buy
1,979
+28
+1% +$3.64K 0.11% 166
2023
Q3 		$264K Buy
1,951
+20
+1% +$2.73K 0.12% 162
2023
Q2 		$276K Buy
+1,931
New +$284K 0.12% 158

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Argonautica Private Wealth Management's AZN Position: Q2 2026 in Review

Argonautica Private Wealth Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 4,087 shares — an estimated $806K sold.

Argonautica Private Wealth Management first reported a position in AZN in Q2 2023 and held it in 12 quarters. The position peaked at $806K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Argonautica Private Wealth Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Argonautica Private Wealth Management sold 4,087 AstraZeneca shares in Q2 2026, an estimated $806K.
  • Argonautica Private Wealth Management first reported a position in AstraZeneca in Q2 2023 and held it in 12 quarters.
  • Argonautica Private Wealth Management's AstraZeneca position peaked at $806K in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.